BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 223 filers reported holding BIONTECH SE in Q1 2021. The put-call ratio across all filers is 1.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $267,798 | -88.3% | 2,465 | -88.4% | 0.01% | -89.5% |
| Q2 2023 | $2,291,138 | +229113700.0% | 21,228 | +303157.1% | 0.08% | – |
| Q1 2023 | $1 | -99.6% | 7 | -99.5% | 0.00% | -100.0% |
| Q4 2022 | $227 | -99.9% | 1,510 | +7.5% | 0.01% | +200.0% |
| Q3 2022 | $190,000 | -88.7% | 1,405 | -87.5% | 0.00% | -92.1% |
| Q2 2022 | $1,682,000 | +56.8% | 11,277 | +79.3% | 0.04% | +280.0% |
| Q1 2022 | $1,073,000 | +69.2% | 6,289 | +155.7% | 0.01% | -9.1% |
| Q4 2021 | $634,000 | -55.2% | 2,460 | -52.5% | 0.01% | -69.4% |
| Q3 2021 | $1,415,000 | -58.3% | 5,182 | -65.8% | 0.04% | -59.1% |
| Q2 2021 | $3,390,000 | +5036.4% | 15,146 | +2391.1% | 0.09% | +8700.0% |
| Q1 2021 | $66,000 | -91.0% | 608 | -93.2% | 0.00% | -95.5% |
| Q4 2020 | $730,000 | +236.4% | 8,959 | +185.7% | 0.02% | +1000.0% |
| Q3 2020 | $217,000 | +3516.7% | 3,136 | +3236.2% | 0.00% | – |
| Q2 2020 | $6,000 | – | 94 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |